Israeli Biotech MeMed Receives $2M Grant for AI-Driven Diagnostics Biobank
Israeli biotech MeMed receives $2 million grant for AI-driven diagnostics biobank to accelerate development of high-risk patient tools.




















Israeli biotech MeMed receives $2 million grant for AI-driven diagnostics biobank to accelerate development of high-risk patient tools.